Molecular Diagnostics Market

Molecular Diagnostics Market (Technology: PCR & Real-time PCR, Hybridization, Microarray, Transcription-mediated Amplification, Next Generation Sequencing, and Others; Application and End-user) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Molecular Diagnostics Market Outlook 2028

  • The global market was valued at US$ 14.99 Mn in 2020
  • It is estimated to expand at a CAGR of 11.1% from 2021 to 2028
  • The global molecular diagnostics industry is expected to reach the value of US$ 37.19 Bn by the end of 2028

Analysts’ Viewpoint on Global Market Scenario

Even though elective procedures have been postponed indefinitely during the ongoing COVID-19 outbreak, healthcare facilities are ensuring continuity in services for key sectors such as blood screening and detection of infectious diseases, among others. However, in many cases, it has been found that late diagnosis of any disease results in rise in the cost of treatment. Hence, companies in the molecular diagnostics market should increase R&D to enable early detection of diseases and invest in marketing of tests to increase awareness about its advantages for early disease diagnosis. Alternatively, the strong growth of molecular diagnostics in Germany can be attributed to the government’s focus on healthcare investments, enhancing the biotechnology sector, and increasing the number of biotechnology companies in the country.

North America and Asia Pacific Witnessing Change in Molecular Diagnostics

North America dominated the global market for molecular diagnostics in 2020, followed by Europe. The region's dominance can be attributed to the increase in diagnostic facilities and the emergence of new players in the region. North America is the leading market for molecular diagnostics due to the rise in investments by governments in support of molecular diagnostic tests. A surge in the incidence of cancer and unhealthy lifestyle leading to severe infectious diseases are fueling the growth of the molecular diagnostics market in the region. Other factors such as the large geriatric population and the rise in demand for personalized medicines are expected to augment the market in North America.

Emerging markets in Asia Pacific hold immense growth potential due to initiatives taken by governments to promote healthcare and robust economic growth. Moreover, improving purchasing power, consumer awareness about health issues, and better disease management are expected to boost the growth of the global market for molecular diagnostics in the Asia Pacific.

Request a sample to get extensive insights into the Molecular Diagnostics Market

Unprecedented Demand for RT-PCR Test During COVID-19 Pandemic Propelling Market Growth

In order to keep the economies running amid the ongoing COVID-19 outbreak, companies in the global molecular diagnostics market are increasing R&D in PCR (Polymerase Chain Reaction) & real-time PCR, hybridization, microarray, transcription-mediated amplification, next-generation sequencing, etc.

The PCR & real-time PCR segment accounted for a leading revenue share of the global market in 2020. The segment is likely to witness strong growth during the forecast period, as the PCR technique is a cost-effective way of copying or amplification of small segments of DNA or RNA. The unprecedented demand for RT-PCR tests during the ongoing pandemic is propelling the market growth.

To understand how our report can bring a difference to your business strategy, Ask for a brochure

Lack of Awareness about Molecular Diagnostic Tests Affecting Market Expansion

Less awareness and ambiguity about diagnostic techniques for detecting various infectious & chronic diseases is a major factor limiting the penetration of tests, such as HIV tests, healthcare-acquired infection tests, and rapid molecular tests in the mycobacterium tuberculosis into the molecular diagnostics market. Therefore, small and medium community medical practitioners in emerging economies such as China and India need to be educated about the availability of these tests, and how these can be used for the prevention and diagnosis of chronic diseases. Stakeholders in this market should increase marketing and awareness about molecular diagnostic tests to increase their acceptance among people in developing economies.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Molecular Diagnostics Market

Increase in Adoption of Molecular Diagnostic Devices in Europe Driving Global Market

Companies in the Europe molecular diagnostics market are focusing on hospitals, diagnostic laboratories, academic & research institutes, and pharmaceutical & biotechnology companies to expand their business activities. Pharmaceutical and biotechnology companies are anticipated to be the fastest growing segment, owing to their increasing investments in research that contribute to the growth in the adoption of molecular diagnostic devices. This segment is closely trailed by academic and research institutes. The growth in this segment can be attributed to the increasing public and private funding for research. European funding organizations are supporting innovative companies in the development of new products and are conducting annual PCR conferences to identify potential innovators of PCR technology.

Automation Technologies Growing Prominent in Molecular Diagnostics

The demand for molecular diagnostic systems has been increasing, owing to the increasing automation in the research process. These systems aid in automating the process of DNA extraction, amplification, and recording the analysis of data. In addition, these systems offer a range of advantages such as increased efficiency, the correctness of the data, and a decrease in the time required for results, which contribute to garnering market growth. 

Companies are increasing efforts toward high-throughput molecular testing of infectious diseases. They are entering into agreements to provide molecular diagnostic tests, which are designed for the detection of various pathogens with a single patient sample.

Molecular Diagnostics Market – Scope of Report

  • According to Transparency Market Research’s latest report on the global market for the historical period, 2017–2019 and forecast period 2021–2028, an increase in the geriatric population, a rise in demand for personalized health care, and a surge in awareness about molecular diagnostics are the key factors projected to drive the global molecular diagnostics industry during the forecast period

A rise in Prevalence of Infectious Diseases and Cancer: Key Driver

  • According to the World Health Organization (WHO), cancer accounts for 8.3 million deaths globally each year, with 70% of new cancer cases expected to be reported in the next 20 years. Each cancer type requires unique treatment. Hence, the rise in the prevalence of cancer and the need for personalized medicine are expected to drive demand for molecular diagnostics during the forecast period. This is likely to provide significant opportunities to players in the market, as it is still in a nascent stage.

Increase in Government Investment in Diagnostic Health Care to Boost Market Growth

  • Governments of several countries are investing in diagnostic health care. According to the World Bank, global public expenditure was 6% of the GDP.
    • In the past few years, healthcare spending in the U.S. increased by 5.8% to reach US$ 3.2 Trn. The overall share of the U.S. economy devoted to healthcare spending was 17.8% in 2015, up from 17.4% in 2014.
    • In 2014, the total healthcare expenditure of the general government in Europe was 7.2% of the GDP

Lack of Awareness to Hamper Market

  • Less awareness and ambiguity about diagnostic techniques for detecting various infectious and chronic diseases is a major factor limiting the penetration of tests, such as HIV tests, health care-acquired infection tests, and rapid molecular tests for mycobacterium tuberculosis, into the molecular diagnostics market. Therefore, small and medium community medical practitioners in emerging economies such as China and India need to be educated about the availability of these tests and how these can be used for the prevention and diagnosis of chronic diseases.
  • Late diagnosis of any disease results in an increase in the cost of treatment

Molecular Diagnostics Industry: Competition Landscape

  • This report profiles major players in the global market for molecular diagnostics based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global molecular diagnostics business is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global molecular diagnostics market are
    • Abbot Laboratories
    • Becton
    • Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • bioMérieux SA
    • Danaher Corporation
    • F. Hoffmann-La Roche Ltd.
    • QIAGEN N.V.
    • Siemens AG
    • Thermo Fisher Scientific, Inc., among others

Molecular Diagnostics Market: Key Developments

  • Key players in the global molecular diagnostics industry are engaged in regulatory approvals, technologically advanced products, the launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global market in the next few years.
  • A few expansion strategies adopted by players operating in the global molecular diagnostics business are:
    • In December 2021, Becton, Dickinson, and Company (BD) announced the expansion of its BD COR system to include MX instruments for high-throughput molecular testing of infectious diseases
    • In March 2021, Roche announced an agreement to acquire GenMark Diagnostics. This acquisition has been carried out so that GenMark can provide molecular diagnostic tests, which are designed for the detection of various pathogens with a single patient sample.
  • The report on the global market discusses individual strategies, followed by company profiles of manufacturers of stem cell products. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global molecular diagnostics industry.

Molecular Diagnostics Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 14.99 Bn

Market Forecast Value in 2028

US$ 37.19 Bn

Growth Rate (CAGR)

11.1%

Forecast Period

2021–2028

Quantitative Units

US$ Bn for Value

Market Analysis

It includes cross-segment analysis at the global as well as regional levels. Moreover, the qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2020)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • By Technology
    • PCR & Real time PCR
    • Hybridization
    • Microarray
    • Transcription-mediated Amplification
    • Next Generation Sequencing
    • Others
  • Application
    • Infectious Diseases
    • Oncology
    • Blood Screening
    • Microbiology
    • Genetic Testing
    • Women's Health
  • End-user
    • Hospitals
    • Diagnostic Laboratories
    • Blood Banks
    • Academics & Research
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • STEMCELL Technologies, Inc.
  • Astellas Pharma, Inc.
  • Cellular Engineering Technologies, Inc.
  • BioTime, Inc.
  • Takara Bio, Inc.
  • U.S. Stem Cell, Inc.
  • BrainStorm Cell Therapeutics, Inc.
  • Cytori Therapeutics, Inc.
  • Osiris Therapeutics, Inc.
  • Caladrius Biosciences, Inc.
  • Others

Customization Scope

Available upon request

Pricing

Available upon request

Molecular Diagnostics Market – Segmentation

Technology
  • PCR & Real-time PCR
  • Hybridization
  • Microarray
  • Transcription-mediated Amplification
  • Next-Generation Sequencing
  • Others
Application
  • Infectious Diseases
  • Virology
  • Bacteriology
  • Oncology
  • Blood Screening
  • Microbiology
  • Genetic Testing
  • Women's Health
End-user
  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Academics & Research
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of molecular diagnostics market?

The global market for molecular diagnostics was worth US$ 14.99 Mn and is projected to reach a value of US$ 37.19 Bn by the end of 2028

What is the anticipated CAGR of the global market for molecular diagnostics in the forecast period?

The global market is anticipated to grow at a CAGR of 11.1% during the forecast period

Which region is expected to project the highest market share in the global molecular diagnostics market?

North America accounted for a major share of the global market for molecular diagnostics

What are the key driving factors for the growth of the molecular diagnostics business?

The market is driven by an increase in the geriatric population, a rise in demand for personalized health care, and a surge in awareness about molecular diagnostics are the key factors projected to drive the global market during the forecast period

Who are the key players in the global molecular diagnostics industry?

Key players in the global market include Abbot Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Danaher Corporation, F. Hoffmann-La Roche Ltd., QIAGEN N.V., Siemens AG, and Thermo Fisher Scientific, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Molecular Diagnostics Market

    4. Market Overview

        4.1. Introduction

            4.1.1. End-user Definition

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Molecular Diagnostics Market Analysis and Forecast, 2017–2028

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Future Market Outlook

        5.2. Key Industry Events

        5.3. Porter’s Five Force Analysis

        5.4. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)

    6. Global Molecular Diagnostics Market Analysis and Forecast, by End-user

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by End-user, 2017–2028

            6.3.1. PCR & Real-time PCR

            6.3.2. Hybridization

            6.3.3. Microarray

            6.3.4. Transcription-mediated Amplification

            6.3.5. Next-Generation Sequencing

            6.3.6. Others

        6.4. Market Attractiveness Analysis, by End-user

    7. Global Molecular Diagnostics Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Application, 2017–2028

            7.3.1. Infectious Diseases

                7.3.1.1. Virology

                7.3.1.2. Bacteriology

            7.3.2. Oncology

            7.3.3. Blood Screening

            7.3.4. Microbiology

            7.3.5. Genetic Testing

            7.3.6. Women’s Health

        7.4. Market Attractiveness Analysis, by Application

    8. Global Molecular Diagnostics Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by End-user, 2017–2028

            8.3.1. Hospitals

            8.3.2. Diagnostics Laboratories

            8.3.3. Blood Banks

            8.3.4. Academics & Research

            8.3.5. Others

        8.4. Market Attractiveness Analysis, by End-user

    9. Global Molecular Diagnostics Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Molecular Diagnostics Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by End-user, 2017–2028

            10.2.1. PCR & Real-time PCR

            10.2.2. Hybridization

            10.2.3. Microarray

            10.2.4. Transcription-mediated Amplification

            10.2.5. Next-Generation Sequencing

            10.2.6. Others

        10.3. Market Value Forecast, by Application, 2017–2028

            10.3.1. Infectious Diseases

                10.3.1.1. Virology

                10.3.1.2. Bacteriology

            10.3.2. Oncology

            10.3.3. Blood Screening

            10.3.4. Microbiology

            10.3.5. Genetic Testing

            10.3.6. Women’s Health

        10.4. Market Value Forecast, by End-user, 2017–2028

            10.4.1. Hospitals

            10.4.2. Diagnostics Laboratories

            10.4.3. Blood Banks

            10.4.4. Academics & Research

            10.4.5. Others

        10.5. Market Value Forecast, by Country, 2017–2028

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By End-user

            10.6.2. By Application

            10.6.3. By End-user

            10.6.4. By Country

    11. Europe Molecular Diagnostics Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by End-user, 2017–2028

            11.2.1. PCR & Real-time PCR

            11.2.2. Hybridization

            11.2.3. Microarray

            11.2.4. Transcription-mediated Amplification

            11.2.5. Next-Generation Sequencing

            11.2.6. Others

        11.3. Market Value Forecast, by Application, 2017–2028

            11.3.1. Infectious Diseases

                11.3.1.1. Virology

                11.3.1.2. Bacteriology

            11.3.2. Oncology

            11.3.3. Blood Screening

            11.3.4. Microbiology

            11.3.5. Genetic Testing

            11.3.6. Women’s Health

        11.4. Market Value Forecast, by End-user, 2017–2028

            11.4.1. Hospitals

            11.4.2. Diagnostics Laboratories

            11.4.3. Blood Banks

            11.4.4. Academics & Research

            11.4.5. Others

        11.5. Market Value Forecast, by Country/Sub-region, 2017–2028

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Italy

            11.5.5. Spain

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By End-user

            11.6.2. By Application

            11.6.3. By End-user

            11.6.4. By Country/Sub-region

    12. Asia Pacific Molecular Diagnostics Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by End-user, 2017–2028

            12.2.1. PCR & Real-time PCR

            12.2.2. Hybridization

            12.2.3. Microarray

            12.2.4. Transcription-mediated Amplification

            12.2.5. Next-Generation Sequencing

            12.2.6. Others

        12.3. Market Value Forecast, by Application, 2017–2028

            12.3.1. Infectious Diseases

                12.3.1.1. Virology

                12.3.1.2. Bacteriology

            12.3.2. Oncology

            12.3.3. Blood Screening

            12.3.4. Microbiology

            12.3.5. Genetic Testing

            12.3.6. Women’s Health

        12.4. Market Value Forecast, by End-user, 2017–2028

            12.4.1. Hospitals

            12.4.2. Diagnostics Laboratories

            12.4.3. Blood Banks

            12.4.4. Academics & Research

            12.4.5. Others

        12.5. Market Value Forecast, by Country/Sub-region, 2017–2028

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis

            12.6.1. By End-user

            12.6.2. By Application

            12.6.3. By End-user

            12.6.4. By Country/Sub-region

    13. Latin America Molecular Diagnostics Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by End-user, 2017–2028

            13.2.1. PCR & Real-time PCR

            13.2.2. Hybridization

            13.2.3. Microarray

            13.2.4. Transcription-mediated Amplification

            13.2.5. Next-Generation Sequencing

            13.2.6. Others

        13.3. Market Value Forecast, by Application, 2017–2028

            13.3.1. Infectious Diseases

                13.3.1.1. Virology

                13.3.1.2. Bacteriology

            13.3.2. Oncology

            13.3.3. Blood Screening

            13.3.4. Microbiology

            13.3.5. Genetic Testing

            13.3.6. Women’s Health

        13.4. Market Value Forecast, by End-user, 2017–2028

            13.4.1. Hospitals

            13.4.2. Diagnostics Laboratories

            13.4.3. Blood Banks

            13.4.4. Academics & Research

            13.4.5. Others

        13.5. Market Value Forecast, by Country/Sub-region, 2017–2028

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By End-user

            13.6.2. By Application

            13.6.3. By End-user

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Molecular Diagnostics Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by End-user, 2017–2028

            14.2.1. PCR & Real-time PCR

            14.2.2. Hybridization

            14.2.3. Microarray

            14.2.4. Transcription-mediated Amplification

            14.2.5. Next-Generation Sequencing

            14.2.6. Others

        14.3. Market Value Forecast, by Application, 2017–2028

            14.3.1. Infectious Diseases

                14.3.1.1. Virology

                14.3.1.2. Bacteriology

            14.3.2. Oncology

            14.3.3. Blood Screening

            14.3.4. Microbiology

            14.3.5. Genetic Testing

            14.3.6. Women’s Health

        14.4. Market Value Forecast, by End-user, 2017–2028

            14.4.1. Hospitals

            14.4.2. Diagnostics Laboratories

            14.4.3. Blood Banks

            14.4.4. Academics & Research

            14.4.5. Others

        14.5. Market Value Forecast, by Country/Sub-region, 2017–2028

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis

            14.6.1. By End-user

            14.6.2. By Application

            14.6.3. By End-user

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (by tier and size of companies)

        15.2. Market Share Analysis, by Company, 2020

        15.3. Company Profiles

            15.3.1. Abbott Laboratories

                15.3.1.1. Company Overview

                15.3.1.2. Business Overview

                15.3.1.3. Financial Overview

                15.3.1.4. SWOT Analysis

                15.3.1.5. Strategic Overview

            15.3.2. Becton, Dickinson and Company

                15.3.2.1. Company Overview

                15.3.2.2. Business Overview

                15.3.2.3. Financial Overview

                15.3.2.4. SWOT Analysis

                15.3.2.5. Strategic Overview

            15.3.3. Bio-Rad Laboratories, Inc.

                15.3.3.1. Company Overview

                15.3.3.2. Business Overview

                15.3.3.3. Financial Overview

                15.3.3.4. SWOT Analysis

                15.3.3.5. Strategic Overview

            15.3.4. BioMérieux SA

                15.3.4.1. Company Overview

                15.3.4.2. Business Overview

                15.3.4.3. Financial Overview

                15.3.4.4. SWOT Analysis

                15.3.4.5. Strategic Overview

            15.3.5. Danaher Corporation

                15.3.5.1. Company Overview

                15.3.5.2. Business Overview

                15.3.5.3. Financial Overview

                15.3.5.4. SWOT Analysis

                15.3.5.5. Strategic Overview

            15.3.6. F. Hoffmann-La Roche Ltd.

                15.3.6.1. Company Overview

                15.3.6.2. Business Overview

                15.3.6.3. Financial Overview

                15.3.6.4. SWOT Analysis

                15.3.6.5. Strategic Overview

            15.3.7. QIAGEN N.V.

                15.3.7.1. Company Overview

                15.3.7.2. Business Overview

                15.3.7.3. Financial Overview

                15.3.7.4. SWOT Analysis

                15.3.7.5. Strategic Overview

            15.3.8. Siemens AG

                15.3.8.1. Company Overview

                15.3.8.2. Business Overview

                15.3.8.3. Financial Overview

                15.3.8.4. SWOT Analysis

                15.3.8.5. Strategic Overview

            15.3.9. Thermo Fisher Scientific Inc.

                15.3.9.1. Company Overview

                15.3.9.2. Business Overview

                15.3.9.3. Financial Overview

                15.3.9.4. SWOT Analysis

                15.3.9.5. Strategic Overview

    List of Table

    Table 01: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2028

    Table 02: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2028

    Table 03: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2017–2028

    Table 04: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2028

    Table 05: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017–2028

    Table 06: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2017–2028

    Table 07: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2028

    Table 08: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2017–2028

    Table 09: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2028

    Table 10: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2028

    Table 11: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2028

    Table 12: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2028

    Table 13: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2017–2028

    Table 14: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2028

    Table 15: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

    Table 16: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2017–2028

    Table 17: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2028

    Table 18: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2017–2028

    Table 19: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2028

    Table 20: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

    Table 21: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2017–2028

    Table 22: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2028

    Table 23: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2017–2028

    Table 24: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2028

    Table 25: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

    Table 26: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2028

    Table 27: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2028

    Table 28: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2017–2028

    Table 29: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2028

    Table 30: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

    List of Figure

    Figure 1: Global Molecular Diagnostic Market Size (US$ Mn) Forecast, 2017–2028

    Figure 2: Global Molecular Diagnostics Market Value Share, by Technology, 2020

    Figure 3: Global Molecular Diagnostics Market Value Share, by Application, 2020

    Figure 4: Global Molecular Diagnostics Market Value Share, by Region, 2020

    Figure 5: Global Molecular Diagnostics Market Value Share, by End-user, 2020

    Figure 6: Global Molecular Diagnostic Market Value Share Analysis, by Technology, 2017 and 2028

    Figure 7: Global Molecular Diagnostic Market Attractiveness Analysis, by Technology, 2021–2028

    Figure 8: Global PCR & Real-time PCR Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

    Figure 9: Global Hybridization Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

    Figure 10: Global Microarray Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

    Figure 11: Global Transcription-mediated Amplification Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

    Figure 12: Global Next-Generation Sequencing Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

    Figure 13: Global Others (Mass Spectrometry etc.) Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

    Figure 14: Global Molecular Diagnostics Market Value Share Analysis, by Application, 2017 and 2028

    Figure 15: Global Molecular Diagnostics Market Attractiveness Analysis, by Application, 2021–2022

    Figure 16: Global Infectious Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

    Figure 17: Global Oncology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

    Figure 18: Global Blood Screening Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

    Figure 19: Global Microbiology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

    Figure 20: Global Genetic Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

    Figure 21: Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

    Figure 22: Global Molecular Diagnostic Market Value Share Analysis, by End-user, 2017 and 2028

    Figure 23: Global Molecular Diagnostic Market Attractiveness Analysis, by End-user, 2021–2022

    Figure 24: Global Hospital Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

    Figure 25: Global Diagnostic Laboratories Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

    Figure 26: Global Blood Banks Centers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

    Figure 27: Global Academics & Research Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

    Figure 28: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2028

    Figure 29: Global Molecular Diagnostics Market Value Share Analysis, by Region, 2017 and 2028

    Figure 30: Global Molecular Diagnostics Market Attractiveness Analysis, by Region, 2021–2022

    Figure 31: North America Molecular Diagnostics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028

    Figure 32: North America Molecular Diagnostics Market Attractiveness Analysis, by Country, 2021–2022

    Figure 33: North America Market Value Share Analysis, by Technology Type, 2017 and 2028

    Figure 34: North America Market Value Share Analysis, by Application, 2017 and 2028

    Figure 35: North America Market Value Share Analysis, by End-user, 2017 and 2028

    Figure 36: North America Market Value Share Analysis, by Country, 2017 and 2028

    Figure 37: North America Market Attractiveness Analysis, by Technology, 2021–2022

    Figure 38: North America Market Attractiveness Analysis, by Application, 2021–2022

    Figure 39: North America Market Attractiveness Analysis, by End-user, 2021–2022

    Figure 40: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, 2017–2028

    Figure 41: Europe Molecular Diagnostics Market Attractiveness Analysis, by Country, 2021–2022

    Figure 42: Europe Molecular Diagnostics Market Value Share Analysis, by Technology, 2017 and 2028

    Figure 43: Europe Molecular Diagnostics Market Value Share Analysis, by Application, 2017 and 2028

    Figure 44: Europe Molecular Diagnostics Market Value Share Analysis, by End-user, 2017 and 2028

    Figure 45: Europe Molecular Diagnostics Market Value Share Analysis, by Country, 2017 and 2028

    Figure 46: Europe Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2021–2022

    Figure 47: Europe Molecular Diagnostics Market Attractiveness Analysis, by Application, 2021–2022

    Figure 48: Europe Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2021–2022

    Figure 49: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, 2017–2028

    Figure 50: Asia Pacific Molecular Diagnostics Market Attractiveness Analysis, by Country, 2021–2022

    Figure 51: Asia Pacific Market Value Share Analysis, by Technology Type, 2017 and 2028

    Figure 52: Asia Pacific Market Value Share Analysis, by Application, 2017 and 2028

    Figure 53: Asia Pacific Market Value Share Analysis, by End-user, 2017 and 2028

    Figure 54: Asia Pacific Market Value Share Analysis, by Country, 2017 and 2028

    Figure 55: Asia Pacific Market Attractiveness Analysis, by Technology, 2021–2022

    Figure 56: Asia Pacific Market Attractiveness Analysis, by Application, 2021–2022

    Figure 57: Asia Pacific Market Attractiveness Analysis, by End-user, 2021–2022

    Figure 58: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, 2017–2028

    Figure 59: Latin America Molecular Diagnostics Market Attractiveness Analysis, by Country, 2021–2022

    Figure 60: Latin America Market Value Share Analysis, by Technology Type, 2017 and 2028

    Figure 61: Latin America Market Value Share Analysis, by Application, 2017 and 2028

    Figure 62: Latin America Market Value Share Analysis, by End-user, 2017 and 2028

    Figure 63: Latin America Market Value Share Analysis, by Country, 2017 and 2028

    Figure 64: Latin America Market Attractiveness Analysis, by Technology, 2021–2022

    Figure 65: Latin America Market Attractiveness Analysis, by Application, 2021–2022

    Figure 66: Latin America Market Attractiveness Analysis, by End-user, 2021–2022

    Figure 67: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, 2017–2028

    Figure 68: Middle East & Africa Molecular Diagnostics Market Attractiveness Analysis, by Country, 2021–2022

    Figure 69: Middle East & Africa Market Value Share Analysis, by Technology Type, 2017 and 2028

    Figure 70: Middle East & Africa Market Value Share Analysis, by Application, 2017 and 2028

    Figure 71: Middle East & Africa Market Value Share Analysis, by End-user, 2017 and 2028

    Figure 72: Middle East & Africa Market Value Share Analysis, by Country, 2017 and 2028

    Figure 73: Middle East & Africa Market Attractiveness Analysis, by Technology, 2021–2022

    Figure 74: Middle East & Africa Market Attractiveness Analysis, by Application, 2021–2022

    Figure 75: Middle East & Africa Market Attractiveness Analysis, by End-user, 2021–2022

    Figure 76: Global Molecular Diagnostics Market Share Analysis, by Company

Copyright © Transparency Market Research, Inc. All Rights reserved